Pregled bibliografske jedinice broj: 169088
Kinetics and activity of arylsulfatase A in leukocytes derived from patients with cerebral palsy
Kinetics and activity of arylsulfatase A in leukocytes derived from patients with cerebral palsy // Congress of the Croatian Society of Biochemistry and Molecular Biology with international participation, Book of Abstracts / Dumić, Jerka (ur.).
Zagreb: Farmaceutsko-biokemijski fakultet Sveučilišta u Zagrebu, 2004. (poster, domaća recenzija, sažetak, znanstveni)
CROSBI ID: 169088 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Kinetics and activity of arylsulfatase A in leukocytes derived from patients with cerebral palsy
Autori
Foretić, Blaženka ; Furač, Ivana ; Vukelić, Željka ; Kalanj-Bognar, Svjetlana
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Congress of the Croatian Society of Biochemistry and Molecular Biology with international participation, Book of Abstracts
/ Dumić, Jerka - Zagreb : Farmaceutsko-biokemijski fakultet Sveučilišta u Zagrebu, 2004
Skup
Congress of the Croatian Society of Biochemistry and Molecular Biology with international participation, HDBMB2004
Mjesto i datum
HOC Bjelolasica, Hrvatska, 30.09.2004. - 02.10.2004
Vrsta sudjelovanja
Poster
Vrsta recenzije
Domaća recenzija
Ključne riječi
arylsulfatase A; kinetics; specific activity; cerebral palsy
Sažetak
Arylsulfatase A (ASA, EC 3.1.6.1) is a lysosomal enzyme involved in sulfatide catabolism. Deficiency of ASA causes metachromatic leukodystrophy, rare autosomal recessive disorder characterized by the storage of cerebroside sulfate mainly in the nervous tissue. The onset and clinical severity of the disease are related to the type of mutation in ASA gene and consequently to the enzyme deficiency. A large number of mutations and polymorphisms in the ASA gene resulting in different levels of decreased enzyme activity have been reported so far. It has been suggested that such mutations may contribute to pathogenesis of neuropsychiatric disorders. Interestingly, none of detected mutations resides in the catalytic site of the enzyme. Physico-chemical properties of the arylsulfatase A have been extensively studied and its anomalous kinetics in biological samples has been described. The aim of this preliminary study was to determine kinetic properties of arylsulfatase A in leukocytes derived from healthy individuals and patients with diagnosis of spastic cerebral palsy. ASA activity was measured by spectrophotometry (lambda=515 nm) using p-nitrocatechol sulfate (pNCS) as chromogenic substrate. Kinetic parameters of leukocyte arylsulfatase A were determined in dependence of substrate (pNCS) concentrations. Results showed decreased ASA activity in samples derived from patients. Previous findings indicated that changes observed in enzyme activities could not always be explained only as the consequence of mutations in the ASA gene. Other (epigenetic) mechanisms may be responsible for such finding, possibly through different modifications and changes in enzyme structure leading to its inefficiency. Also, the analysis of kinetic properties of the arylsulfatase A may provide additional information and better insight into the mechanism of altered activity of this enzyme in cerebral palsy and several other pathological conditions.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb
Profili:
Svjetlana Kalanj-Bognar
(autor)
Blaženka Foretić
(autor)
Ivana Furač
(autor)
Željka Vukelić
(autor)